These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 20831677)
1. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis. Hiraki Y; Onga T; Mizoguchi A; Tsuji Y J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677 [TBL] [Abstract][Full Text] [Related]
2. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods. Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680 [TBL] [Abstract][Full Text] [Related]
3. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus. Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996 [TBL] [Abstract][Full Text] [Related]
7. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis. Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495 [TBL] [Abstract][Full Text] [Related]
8. Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia. Suzuki Y; Kawasaki K; Sato Y; Tokimatsu I; Itoh H; Hiramatsu K; Takeyama M; Kadota J Chemotherapy; 2012; 58(4):308-12. PubMed ID: 23147106 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin dosing and monitoring. Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006 [No Abstract] [Full Text] [Related]
10. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy. Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340 [TBL] [Abstract][Full Text] [Related]
11. New target concentrations for vancomycin in Hong Kong. You JH; Chow SS; Lui JW; Ip M Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378 [No Abstract] [Full Text] [Related]
12. Population pharmacokinetics of vancomycin in Japanese adult patients. Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127 [TBL] [Abstract][Full Text] [Related]